News
Period tracker app Flo introduces ‘anonymous mode’ after Roe outcome
Period tracker app Flo is introducing an ‘anonymous mode’ as a response to Roe decision.

After a week since the Roe decision, the period tracker app Flo has announced the introduction of an ‘anonymous mode’ that will protect users from identification.
The announcement has taken place on the app’s social media, as a response to users concerns about how third parties might be able to access their health data. Flo has reassured its users that the new ‘anonymous mode’ will remove personal emails, names and technical data from the users’ accounts.
Users will be able to access the anonymous mode through the Android and iOS app’s settings with the possibility of still enjoying most of the app’s benefits.
The company stated that this new feature was already in the making, but that the Roe decision accelerated its development.
Anonymous Mode will be available to all users in the coming weeks. pic.twitter.com/ZlgnUvTIlI
— Flo Period Tracker (@flotracker) June 30, 2022
Rachel McConnell, director of user experience, said in a statement “now, more than ever, women deserve to access, track, and gain insight into their personal health information without fearing for their safety.”
“By offering anonymous mode, we’re granting another layer of security for our users so they can continue to gain valuable health insights about their bodies without anxiety or concern,” she added.
“Flo will always stand up for the health of women, and this includes providing our users with full control other their data,” added Susanne Schumacher, Flo’s Data Protection Officer. “Flo will never share or sell user data, and only collects data when we have a legal basis to do so and when our users have given their informed content. Any data we do collect is fully encrypted, and this will never change.”
Founded in April 2015, Flo is the most popular women’s health app globally with a 230 million community that enjoys its features in 22 different languages. Flo provides personalised health insights, expert tips and cycle and ovulation tracking to support women during their reproductive lives aiming to build a better future for female health.
Despite the introduction of this new feature, Flo has been subjected to some allegations by the Wall Street Journal that found that the app was sharing its users’ data with Facebook every time they logged in their period dates.
Following these allegations Flo has reached a settlement with the Federal Trade Commission that requires the app to review its privacy practices and get app users’ consent before sharing their data.
While Flo denied the allegations, the investigation leaves room for skepticism about how period apps share their users’ health data and about how reliable they really are.
Period apps and privacy after Roe reversal

On a typical period tracking app the user inserts what day her flow has started, when it stopped, how heavy it was and other possible symptoms. This allows the app to create patterns about the users’ periods, having access to when the next flow may come, when they might be most fertile, and mainly about when they miss a period.
The fear amongst women is that law enforcement could use personal data collected from these apps in order to identify women seeking an abortion.
Until this past May, a recent Vice investigation has found that anyone could buy weekly trove of data on clients at more than 600 Planned Parenthood sites around the US for as little as $160.
This is possible only thanks to HIPAA, the 1996 American Health Insurance Portability and Accountability Act, which only protects the privacy of personal data at a doctor office. The Act does not protect any data that tech companies or third-part apps collect from the user.
Alexandra Reeve Givens, CEO of a Washington-based digital rights non profit, said “In the digital age, this decision opens the door to law enforcement and private bounty hunters seeking vast amount of private data from ordinary Americans.”
Multi-billion companies such as Google and Apple haven’t released any statement yet to inform their users on how they might cooperate with law enforcement.
“Individuals seeking abortions and other reproductive health care will become particularly vulnerable to piracy harms, including through the collection and sharing of their location data,” said the four Democratic lawmakers who asked federal regulators to investigate Apple and Google.
“Data brokers are already selling, licensing and sharing the location information of people that visit abortion providers to anyone with a credit card.” They added.
Wellness
Newly-launched Female Health Hub will support grassroots football players

A new Female Health Hub launched by the English FA will support women and girls in grassroots football in England with trusted advice on health issues affecting play.
The hub brings together expert-backed guidance, practical tools and player insights in one place, giving women and girls practical advice and reassurance on female health in football.
It has four core aims: to help women and girls better understand their bodies and how female health affects performance and participation, to educate players on key health topics and when to seek further advice or support, to provide practical strategies to help navigate common female health challenges, and to help break down taboos and normalise conversations around female health in football.
Users of the hub will also be able to hear directly from members of the England women’s national team, who share their own experiences of navigating female health matters while playing at the highest level of the game.
“Our ambition is to create a game where women and girls can thrive,” said Sue Day, the FA’s director of women’s football.
“To achieve that, it’s essential that players feel supported in environments that understand and respond to their female health needs.
“We’ve heard directly from grassroots players that they want better information and support around female health, but that they often don’t know where to find it.
“The launch of the Female Health Hub marks an important step in changing the landscape.
“We want every player to feel confident in her own skin and supported without judgment, so she can feel empowered by her body, rather than held back by it.”
The platform was launched following research conducted by the FA that highlighted the need for better education and support around female health in football.
According to the FA, 88 per cent of adult players surveyed said their menstrual cycle has an impact on their ability to train or play, but 86 per cent reported they had never received education about the menstrual cycle in relation to football performance and training.
The research also found 64 per cent of women experience issues related to sports bras or breast health while playing football, despite sports bras being considered one of the most important pieces of playing kit.
Players also expressed strong interest in learning more about injury prevention, at 87 per cent, nutrition, at 84 per cent, and mental health, at 77 per cent, in relation to female health.
The first phase of the Female Health Hub focuses on three of the most requested topics: menstrual health, breast health and injury resilience, with further content to follow, including nutrition and pelvic health guidance.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Fertility
Genetic carrier screening before pregnancy: What to know

Article produced in association with London Pregnancy Clinic and Jeen Health
For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.
Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.
As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.
What Carrier Screening Tests For
Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.
In most cases, carriers are entirely unaware of their status.
The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.
The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.
The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.
Who Is Most Likely to Benefit
Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:
- Couples with a family history of a known inherited condition
- Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
- Couples pursuing fertility treatment, where genetic information informs treatment planning
- Those who wish to have the most complete picture of their reproductive health before conception
Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.
How the Test Is Performed
Carrier screening is typically carried out on a blood or saliva sample.
For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.
In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.
London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.
Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.
What Happens If Both Partners Are Carriers
If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.
These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.
The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.
Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.
The Role of Pre-Conception Services
Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.
London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.
Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.
Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.
This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.
Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Menopause4 weeks agoCalifornia plans US$3.4m menopause care overhaul
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
News2 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up















3 Comments